Clinical Trial

Pancreatic Cancer Clinical Trial 2015-062

[LCID Study Number: 2015-062]

Biomarkers for Early Detection of Pancreatic Cancer in Patients with New-Onset Diabetes Mellitus

The purpose of this research study is to develop a screening blood test that can help to identify people with diabetes who are at risk of having pancreatic cancer.

Disease/Condition: Pancreatic Cancer

Department: Translational Lab

Location(s): Lahey Hospital & Medical Center (Burlington)

Primary Contact Email:

Clinical Trial Details

Protocol #: 2015-062

Principal Investigator(s): Kimberly Rieger-Christ

Study Coordinator(s): Sanjna Das

Trial Phase: Sponsor Initiated Study Observational